Roxadustat also improved the insulin-stimulated glycogen synthesis in this subgroup of myotubes from donors with type 2 diabetes (1.3-fold increase vs insulin-only condition) (p=0.0296) (Fig. 3d). Here, INS is linked to type 2 diabetes mellitus.